Functional Mitral Regurgitation following Successful Living Donor Kidney Transplant: The VINTAGE Study.

IF 2.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Sumi Hidaka, Mizuki Yamano, Yasuhiro Mochida, Kazunari Tanabe, Shuzo Kobayashi
{"title":"Functional Mitral Regurgitation following Successful Living Donor Kidney Transplant: The VINTAGE Study.","authors":"Sumi Hidaka, Mizuki Yamano, Yasuhiro Mochida, Kazunari Tanabe, Shuzo Kobayashi","doi":"10.1159/000551778","DOIUrl":null,"url":null,"abstract":"<p><p>Introduction Functional mitral regurgitation (FMR) is prevalent in CKD patients, but few studies have evaluated the effect of kidney transplant (KT) on FMR. This study aimed to clarify KT's effect on FMR. Methods This study included 115 living donor KT recipients (2012-2023). Primary outcome was change in FMR severity (5 categories: none to severe) based on echocardiographic findings before and 1 year post-KT. Aortic regurgitation (AR) severity and changes in left atrial diameter (LAD), left ventricular end-diastolic dimension (LVDd), ANP, and BNP levels were also assessed. Change in FMR and AR severity was assessed using Wilcoxon signed-rank tests. Multivariable logistic regression models were used to identify factors associated with the worsening of FMR and AR. Results At baseline, 76.5% had trivial FMR; 22.6% had mild/moderate/severe FMR. One year post-KT, moderate/severe FMR disappeared. Overall, FMR improved in 19.1%, remained unchanged in 73.1%, and worsened in 7.8%. FMR severity distribution significantly changed (P=0.004). Reductions in LAD/LVDd aligned with decreased ANP/BNP. Multivariable analysis identified acute ABMR as an independent factor for worsening FMR (OR 4.02, 95% CI 1.81-8.91, P < 0.001). No significant AR improvement was observed (P=0.377). A history of arrhythmia (OR 2.68, 95% CI 1.28-5.64, P = 0.009) and stroke (OR 2.27, 95% CI 1.12-4.59, P = 0.023) were identified as an independent factor for worsening AR. Conclusions KT is associated with an improvement in FMR among patients with kidney failure (KF). This is likely due to LA/LV reverse remodeling from reduced volume/pressure overload. However, this benefit may diminish with graft dysfunction (e.g., acute rejection). Conversely, KT is not associated with an improvement in AR. Our findings highlight another important cardioprotective benefit of successful KT. Further prospective studies are needed to better understand this association.</p>","PeriodicalId":9584,"journal":{"name":"Cardiorenal Medicine","volume":" ","pages":"1-22"},"PeriodicalIF":2.9000,"publicationDate":"2026-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiorenal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000551778","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction Functional mitral regurgitation (FMR) is prevalent in CKD patients, but few studies have evaluated the effect of kidney transplant (KT) on FMR. This study aimed to clarify KT's effect on FMR. Methods This study included 115 living donor KT recipients (2012-2023). Primary outcome was change in FMR severity (5 categories: none to severe) based on echocardiographic findings before and 1 year post-KT. Aortic regurgitation (AR) severity and changes in left atrial diameter (LAD), left ventricular end-diastolic dimension (LVDd), ANP, and BNP levels were also assessed. Change in FMR and AR severity was assessed using Wilcoxon signed-rank tests. Multivariable logistic regression models were used to identify factors associated with the worsening of FMR and AR. Results At baseline, 76.5% had trivial FMR; 22.6% had mild/moderate/severe FMR. One year post-KT, moderate/severe FMR disappeared. Overall, FMR improved in 19.1%, remained unchanged in 73.1%, and worsened in 7.8%. FMR severity distribution significantly changed (P=0.004). Reductions in LAD/LVDd aligned with decreased ANP/BNP. Multivariable analysis identified acute ABMR as an independent factor for worsening FMR (OR 4.02, 95% CI 1.81-8.91, P < 0.001). No significant AR improvement was observed (P=0.377). A history of arrhythmia (OR 2.68, 95% CI 1.28-5.64, P = 0.009) and stroke (OR 2.27, 95% CI 1.12-4.59, P = 0.023) were identified as an independent factor for worsening AR. Conclusions KT is associated with an improvement in FMR among patients with kidney failure (KF). This is likely due to LA/LV reverse remodeling from reduced volume/pressure overload. However, this benefit may diminish with graft dysfunction (e.g., acute rejection). Conversely, KT is not associated with an improvement in AR. Our findings highlight another important cardioprotective benefit of successful KT. Further prospective studies are needed to better understand this association.

活体肾移植成功后的功能性二尖瓣返流:VINTAGE研究。
功能二尖瓣反流(FMR)在CKD患者中普遍存在,但很少有研究评估肾移植(KT)对FMR的影响。本研究旨在阐明KT对FMR的影响。方法本研究纳入2012-2023年115例KT活体供体受者。主要结局是基于术前和术后1年超声心动图结果的FMR严重程度的变化(5类:无至严重)。主动脉瓣反流(AR)严重程度和左房内径(LAD)、左室舒张末期尺寸(LVDd)、ANP和BNP水平的变化也被评估。使用Wilcoxon符号秩检验评估FMR和AR严重程度的变化。多变量logistic回归模型用于确定与FMR和AR恶化相关的因素。结果基线时,76.5%的患者FMR轻微;22.6%为轻度/中度/重度FMR。kt后1年,中度/重度FMR消失。总体而言,FMR改善的占19.1%,保持不变的占73.1%,恶化的占7.8%。FMR严重程度分布显著改变(P=0.004)。LAD/LVDd的降低与ANP/BNP的降低一致。多变量分析发现急性ABMR是FMR恶化的独立因素(OR 4.02, 95% CI 1.81-8.91, P < 0.001)。未观察到明显的AR改善(P=0.377)。心律失常史(OR 2.68, 95% CI 1.28-5.64, P = 0.009)和卒中史(OR 2.27, 95% CI 1.12-4.59, P = 0.023)被确定为AR恶化的独立因素。结论:肾衰竭(KF)患者中KT与FMR改善相关。这可能是由于容量/压力过载减少导致的左室/左室反向重构。然而,这种益处可能会随着移植物功能障碍(如急性排斥反应)而减弱。相反,KT与AR的改善无关。我们的研究结果强调了成功的KT的另一个重要的心脏保护益处。需要进一步的前瞻性研究来更好地理解这种关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiorenal Medicine
Cardiorenal Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-UROLOGY & NEPHROLOGY
CiteScore
5.40
自引率
2.60%
发文量
25
审稿时长
>12 weeks
期刊介绍: The journal ''Cardiorenal Medicine'' explores the mechanisms by which obesity and other metabolic abnormalities promote the pathogenesis and progression of heart and kidney disease (cardiorenal metabolic syndrome). It provides an interdisciplinary platform for the advancement of research and clinical practice, focussing on translational issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书